RecruitingNot ApplicableNCT06512064

Acoustic Waveform Respiratory Evaluation

Advancing Telemedicine in Pulmonology: Acoustic-waveform Respiratory Evaluation (AWARE) Via Sensing and Machine Learning on Smartphones

Sponsor

Indiana University

Enrollment

800 participants

Start Date

Jul 23, 2024

Study Type

INTERVENTIONAL

Conditions

Healthy Control Asthma COPD Cystic Fibrosis Bronchiectasis Ciliary Motility Disorders Airway Malacia

Summary

The study will evaluate the feasibility of using smartphone speakers and microphones to evaluate the caliber of the airways, detect airway obstruction, aid in airway disease diagnosis, and identify disease exacerbations.

Eligibility

Min Age: 8 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a new non-invasive breathing test device called AWARE to see how accurately it measures airway function compared to standard lung function tests (spirometry and oscillometry) in both healthy people and those with lung conditions like asthma, COPD, or cystic fibrosis. **You may be eligible if...** - You are between 8 and 70 years old - You are able to perform breathing tests (spirometry and oscillometry) - You are either a healthy person with no respiratory disease OR have a doctor-confirmed diagnosis of asthma, COPD, cystic fibrosis, or another airway disease - You can provide written consent (and assent if a child) **You may NOT be eligible if...** - You are unable or unwilling to perform the breathing tests - You have a condition that the study team believes may interfere with the accuracy of the results Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.